menu
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Technology
DNase I Oncology Platform
Publications
Pipeline
Overview
XBIO-015
XBIO-020
News & Media
Press Releases
Presentations
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
Proxy Materials
SEC Filings
Corporate Governance
Contact
Xenetic Biosciences, Inc. on Twitter
Xenetic Biosciences, Inc. on Facebook
Xenetic Biosciences, Inc. on LinkedIn
Nasdaq: XBIO
Investors
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
Financial Information
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Proxy Materials
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filter Filings:
View All
10-K
10-K/A
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-Q
PRE 14A
PRE 14C
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
05/20/19
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Related Documents
EX-10.1
66
05/15/19
S-1
General form of registration statement for all companies including face-amount certificate companies
Related Documents
EX-23.1
155
05/13/19
S-4/A
Registration of securities issued in business combination transactions
Related Documents
EX-5.1
EX-23.1
EX-99.2
415
05/13/19
8-K/A
Current report filing
Related Documents
EX-2.1
EX-10.1
165
05/13/19
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Related Documents
EX-2.1
EX-10.1
165
05/13/19
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
3
05/13/19
8-K
Current report filing
Related Documents
EX-99.1
7
05/13/19
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
29
04/30/19
10-K/A
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-31.3
EX-31.4
21
04/24/19
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
3
<< Previous
1...
17
18
19
20
21
22
23
24
25
26
...43
Next >>
Get Email Alerts
Stay informed about our latest news and updates
Sign up Today